148 related articles for article (PubMed ID: 11596128)
1. Glial cells as targets for cytotoxic immune mediators.
Benn T; Halfpenny C; Scolding N
Glia; 2001 Nov; 36(2):200-11. PubMed ID: 11596128
[TBL] [Abstract][Full Text] [Related]
2. EAE, EAN and galactocerebroside sera bind to oligodendrocytes and Schwann cells.
Lisak RP; Saida T; Kennedy PG; Saida K; Silberberg DH; Leibowitz S
J Neurol Sci; 1980 Nov; 48(2):287-96. PubMed ID: 7000981
[TBL] [Abstract][Full Text] [Related]
3. [Antibodies to myelin cerebrosides and their role in the pathogenesis of autoimmune demyelinating diseases (review)].
Taranova NP; Kirchik OS
Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(12):1863-72. PubMed ID: 3911691
[No Abstract] [Full Text] [Related]
4. Complement mediated serum cytotoxicity against oligodendrocytes: a comparison with other cells of the oligodendrocyte-type 2 astrocyte lineage.
Scolding NJ; Morgan BP; Campbell AK; Compston DA
J Neurol Sci; 1990 Jul; 97(2-3):155-62. PubMed ID: 2205708
[TBL] [Abstract][Full Text] [Related]
5. Myelin regeneration in demyelinating disorders: new developments in biology and clinical pathology.
Zawadzka M; Franklin RJ
Curr Opin Neurol; 2007 Jun; 20(3):294-8. PubMed ID: 17495623
[TBL] [Abstract][Full Text] [Related]
6. [Recent progress in multiple sclerosis research: astrocytopathy in demyelinating diseases].
Kira J
Rinsho Shinkeigaku; 2010 Nov; 50(11):788-93. PubMed ID: 21921443
[TBL] [Abstract][Full Text] [Related]
7. Immune mechanisms in the pathogenesis of demyelinating diseases.
Scolding N; Linington C; Compston A
Autoimmunity; 1989; 4(1-2):131-42. PubMed ID: 2491638
[TBL] [Abstract][Full Text] [Related]
8. Do patients with demyelinating disease have antibodies against human glial cells in their sera?
Kennedy PG; Lisak RP
J Neurol Neurosurg Psychiatry; 1981 Feb; 44(2):164-7. PubMed ID: 7012279
[TBL] [Abstract][Full Text] [Related]
9. Killing of rat glial cells by complement: deficiency of the rat analogue of CD59 is the cause of oligodendrocyte susceptibility to lysis.
Piddlesden SJ; Morgan BP
J Neuroimmunol; 1993; 48(2):169-75. PubMed ID: 7693753
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody 14E recognizes an antigen common to human oligodendrocytes, Schwann cells, Bergmann glia, and a subpopulation of reactive glia.
Newcombe J; Naik N; Cuzner ML
Neurochem Res; 1992 Sep; 17(9):933-8. PubMed ID: 1407280
[TBL] [Abstract][Full Text] [Related]
11. Live imaging of remyelination after antibody-mediated demyelination in an ex-vivo model for immune mediated CNS damage.
Harrer MD; von Büdingen HC; Stoppini L; Alliod C; Pouly S; Fischer K; Goebels N
Exp Neurol; 2009 Apr; 216(2):431-8. PubMed ID: 19320002
[TBL] [Abstract][Full Text] [Related]
12. Behaviour of oligodendrocytes and Schwann cells in an experimental model of toxic demyelination of the central nervous system.
Graça DL; Bondan EF; Pereira LA; Fernandes CG; Maiorka PC
Arq Neuropsiquiatr; 2001 Jun; 59(2-B):358-61. PubMed ID: 11460179
[TBL] [Abstract][Full Text] [Related]
13. Neural cell markers and their applications to neurology.
Kennedy PG
J Neuroimmunol; 1982 Jan; 2(1):35-53. PubMed ID: 6185534
[TBL] [Abstract][Full Text] [Related]
14. Astrocytes, oligodendrocytes, and Schwann cells share a common antigenic determinant that cross-reacts with myelin basic protein: identification with monoclonal antibody.
Brenner T; Lisak RP; Rostami A; Pleasure DE; Silberberg DH
J Neurosci; 1986 Jul; 6(7):1925-33. PubMed ID: 2426423
[TBL] [Abstract][Full Text] [Related]
15. Generation of oligodendroglial progenitors in acute inflammatory demyelinating lesions of the rat brain stem is associated with demyelination rather than inflammation.
Di Bello IC; Dawson MR; Levine JM; Reynolds R
J Neurocytol; 1999; 28(4-5):365-81. PubMed ID: 10739577
[TBL] [Abstract][Full Text] [Related]
16. Studies of autoimmunity in multiple sclerosis.
Whitaker JN; Snyder DS
CRC Crit Rev Clin Neurobiol; 1984; 1(1):45-82. PubMed ID: 6400508
[TBL] [Abstract][Full Text] [Related]
17. The action of Guillain-Barrĕ syndrome serum on myelin. A tissue culture and electron microscopic analysis.
Dubois-Dalcq M; Buyse M; Buyse G; Gorce F
J Neurol Sci; 1971 May; 13(1):67-83. PubMed ID: 5105788
[No Abstract] [Full Text] [Related]
18. Inflammatory mediators in demyelinating disorders of the CNS and PNS.
Hartung HP; Jung S; Stoll G; Zielasek J; Schmidt B; Archelos JJ; Toyka KV
J Neuroimmunol; 1992 Oct; 40(2-3):197-210. PubMed ID: 1331168
[TBL] [Abstract][Full Text] [Related]
19. Autoimmunoreactivity to Schwann cells in patients with inflammatory neuropathies.
Kwa MS; van Schaik IN; De Jonge RR; Brand A; Kalaydjieva L; van Belzen N; Vermeulen M; Baas F
Brain; 2003 Feb; 126(Pt 2):361-75. PubMed ID: 12538403
[TBL] [Abstract][Full Text] [Related]
20. Serum-mediated Schwann cell cytotoxicity in the Guillain-Barré syndrome.
Lisak RP; Kuchmy D; Armati-Gulson PJ; Brown MJ; Sumner AJ
Neurology; 1984 Sep; 34(9):1240-3. PubMed ID: 6540410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
